New drug duo aims to outperform standard care in Hard-to-Treat stomach cancer
NCT ID NCT06346197
First seen Nov 18, 2025 · Last updated May 06, 2026 · Updated 23 times
Summary
This phase 3 study compares a new two-drug immunotherapy (botensilimab + balstilimab) against the current standard treatment (chemotherapy plus nivolumab) in people with advanced or metastatic stomach or esophageal cancer that has a specific genetic feature (MSI-H/dMMR). The goal is to see if the new combination helps patients live longer. About 132 adults whose tumors have not been treated before will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Brest
RECRUITINGBrest, 29000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Poitiers
RECRUITINGPoitiers, 86000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Léon Bérard
RECRUITINGLyon, 69008, France
Contact Email: •••••@•••••
-
Hôpital Privé Jean Mermoz
RECRUITINGLyon, 69008, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Mutualiste Montsouris
RECRUITINGParis, 75000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Paoli Calmettes
RECRUITINGMarseille, 13000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.